Agile Therapeutics, Inc. (“Agile”) (OTCQB: AGRX), a women’s healthcare company, announces the completion of the acquisition of Agile by Insud Pharma, S.L. (“Insud”) a global pharmaceutical group based in Spain with a 45-year track record and a presence in over 50 countries. The former holders of Agile common stock voted to approve the acquisition at a special meeting of stockholders on August 22, 2024. Upon closing of the acquisition, former shareholders of Agile became entitled to receive $1.52 per share in cash, net of assumed liabilities and estimated transaction costs for an approximate total enterprise value of $45 million.
Read the full article: Agile Therapeutics Inc. Announces Completion of Acquisition by Insud Pharma, S.L. //
Source: https://www.globenewswire.com/en/news-release/2024/08/26/2935841/30925/en/Agile-Therapeutics-Inc-Announces-Completion-of-Acquisition-by-Insud-Pharma-S-L.html